Bollard Group LLC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q1 2022$13,000
-27.8%
6800.0%0.00%
-100.0%
Q4 2021$18,000
-35.7%
6800.0%0.00%0.0%
Q3 2021$28,000
-28.2%
6800.0%0.00%0.0%
Q2 2021$39,000
+34.5%
6800.0%0.00%0.0%
Q1 2021$29,000
-39.6%
6800.0%0.00%
-50.0%
Q4 2020$48,000
+152.6%
6800.0%0.00%
+100.0%
Q3 2020$19,000
-5.0%
6800.0%0.00%0.0%
Q2 2020$20,0006800.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q2 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders